Skip to main content
December 8, 2024
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Refractory Ovarian Cancer
Ovarian Cancer Treatment
Botensilimab + Balstilimab Produces High Response Rates in Advanced Ovarian Cancer
By Dr. C.H. Weaver M.D.
Apr 8, 2023
CLOSE
CLOSE
CLOSE
CLOSE